Table 2.
Results of sensitivity analysis.
| Outcomes | Deletion | Result | |
|---|---|---|---|
| 6MWD | Dariusz et al. 2008 | χ 2=4.44, P<0.0001, I2=10% | MD47.48, 95% CI: 25.99 to 68.97 |
| He et al. 2016 | χ 2=4.01, P<0.00001, I2=0% | MD51.77, 95% CI: 30.27 to 73.27 | |
| Jackson et al. 2014 | χ 2=2.48, P<0.00001, I2=0% | MD53.72, 95% CI: 32.91 to 74.52 | |
| Nishiyama et al. 2008 | χ 2=4.48, P <0.0001, I2=11% | MD49.41, 95% CI: 27.00 to 71.83 | |
| Vainshelboim et al. 2015 | χ 2=4.50, P <0.00001, I2=11% | MD48.67, 95% CI: 28.10 to 69.24 | |
| Vainshelboim et al. 2016 | χ 2=1.66, P =0.0004, I2=0% | MD39.85, 95% CI: 17.79 to 61.91 | |
| SGRQ scores | Gaunaurdet al.2014 | χ 2=0.82, P =0.0002, I2=0% | MD-7.11, 95% CI: -10.79 to -3.43 |
| Nishiyama et al. 2008 | χ 2=3.26, P<0.0001, I2=39% | MD-8.48, 95% CI: -12.60 to -4.37 | |
| Vainshelboim et al. 2015 | χ 2=2.87, P=0.0001, I2=30% | MD-9.17, 95% CI: -13.83 to -4.52 | |
| Vainshelboim et al. 2016 | χ 2=3.20, P=0.0009, I2=38% | MD-7.14, 95% CI: -11.36 to -2.93 | |
| FVC% | He et al. 2016 | χ 2=1.23, P=0.007, I2=19% | MD4.00, 95 %CI: -0.32 to8.32 |
| Vainshelboim et al. 2015 | χ 2=0.48, P=0.003, I2=0% | MD4.68, 95% CI: 0.55 to 8.81 | |
| Vainshelboim et al. 2016 | χ 2=0.20, P=0.36, I2=0% | MD2.15, 95% CI: -2.42 to 6.72 | |
| DLCO% | He et al. 2016 | χ 2=0.02, P=0.42, I2=0% | MD1.72, 95% CI: -2.43 to 5.87 |
| Vainshelboim et al. 2015 | χ 2=0.98, P=0.10, I2=0% | MD3.59, 95% CI: - 0.66 to7.84 | |
| Vainshelboim et al. 2016 | χ 2=0.76, P=0.07, I2=0% | MD3.74, 95% CI: -0.35 to7.84 | |